News

Institute launches a new AI initiative to power biological research

Rachel Scanza
By Rachel Scanza
Dec. 14, 2024

With artificial intelligence (AI) poised to greatly accelerate the pace for novel discoveries in foundational biological research, the Stowers Institute launched the Office of Scientific Leadership AI Initiative, a new program designed to advance capabilities in machine learning and AI for addressing critical biological questions. Investigator Julia Zeitlinger, Ph.D., has been appointed to lead this effort and leverage cutting-edge computational techniques to accelerate scientific discoveries and drive innovation in biological research.

From left to right: Julia Zeitlinger, Ph.D., Jay Unruh, Ph.D., and Evelyn Travnik
From left to right: Julia Zeitlinger, Ph.D., Jay Unruh, Ph.D., and Evelyn Travnik

Zeitlinger will work to develop and execute a long-term strategy to build world-class AI-powered computational expertise. She will head the steering committee that, together with Chief Information Officer Evelyn Travnik and Director of Scientific Data Jay Unruh, Ph.D., prioritizes and implements computational efforts across the organization. She also advises the Stowers Fellows program and the Graduate School to attract, support, and maintain computational talent at the Institute.

“Biology is incredibly complex, and AI is an excellent way to detect the underlying patterns and rules. A great example is the information encoded in our DNA, how it us used to create gene products like proteins, and how those gene products function to support life,” said Zeitlinger. “I am passionate about leading the Institute’s new initiative to promote AI in our scientific research. It is both an exciting challenge and a huge opportunity.”

A fundamental biological quest is to understand how variations within our genetic code and the molecules arising from it not only make us unique but can also underlie disease or disease susceptibility. AI’s predictive capabilities can guide targeted experimental approaches to identify how these variations impact gene regulation and protein function, key factors governing development, health, and disease.

“Many of our investigators including Zeitlinger and our Technology Center scientists are engaged in the pursuit of understanding how sequences within our DNA genetic blueprint control gene activity and how the shape of proteins affects their function,” said Stowers Scientific Director Kausik Si, Ph.D.

“Leveraging the power of AI will enable researchers Institute-wide to answer questions that remain some of the biggest biological mysteries for the benefit of all,” said Stowers President and Chief Scientific Officer Alejandro Sánchez Alvarado, Ph.D.

This article is republished from Stowers News. Read the original here.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Rachel Scanza
Rachel Scanza

Rachel Scanza is a senior science writer at the Stowers Institute for Medical Research, where she translates complex science for a broad audience to author press releases, news stories, and features. Scanza earned a Ph.D. in atmospheric science from Cornell University and continued to investigate atmospheric aerosols on climate as a postdoctoral fellow at Pacific Northwest National Laboratory.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Mapping fentanyl’s cellular footprint
Journal News

Mapping fentanyl’s cellular footprint

Dec. 4, 2025

Using a new imaging method, researchers at State University of New York at Buffalo traced fentanyl’s effects inside brain immune cells, revealing how the drug alters lipid droplets, pointing to new paths for addiction diagnostics.

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Cholesterol as a novel biomarker for Fragile X syndrome
Journal News

Cholesterol as a novel biomarker for Fragile X syndrome

Nov. 28, 2025

Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.

How lipid metabolism shapes sperm development
Journal News

How lipid metabolism shapes sperm development

Nov. 26, 2025

Researchers at Hokkaido University identify the enzyme behind a key lipid in sperm development. The findings reveal how seminolipids shape sperm formation and may inform future diagnostics and treatments for male infertility.

Mass spec method captures proteins in native membranes
Journal News

Mass spec method captures proteins in native membranes

Nov. 25, 2025

Yale scientists developed a mass spec protocol that keeps proteins in their native environment, detects intact protein complexes and tracks drug binding, offering a clearer view of membrane biology.

Laser-assisted cryoEM method preserves protein structure
Journal News

Laser-assisted cryoEM method preserves protein structure

Nov. 25, 2025

University of Wisconsin–Madison researchers devised a method that prevents protein compaction during cryoEM prep, restoring natural structure for mass spec studies. The approach could expand high-resolution imaging to more complex protein systems.